Patient Guide: A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06698575
Status: 🟢 Enrolling Now
Condition: Recurrent Genital Herpes Simplex Type 2
Phase: PHASE1

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Kansas City, Missouri
  • • Rochester, New York
  • • Seattle, Washington
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes - Join Clinical Trial NCTNCT06698575

How to Join This Clinical Trial - NCTNCT06698575

Learn how to participate in this PHASE1 trial studying an investigational therapy for Recurrent Genital Herpes Simplex Type 2. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Recurrent Genital Herpes Simplex Type 2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Recurrent Genital Herpes Simplex Type 2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06698575 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Kansas City, Missouri 64114 - United States

Status: RECRUITING

Clinical Research Site

Rochester, New York 14609 - United States

Status: RECRUITING

Clinical Research Site

Seattle, Washington 98104 - United States

Status: RECRUITING

Clinical Research Site

Seattle, Washington 98104 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Melbourne, Au 3021 - Australia

Status: RECRUITING

Clinical Research Site

Darlinghurst, 2010 - Australia

Status: RECRUITING

Clinical Research Site

Parkville, 3050 - Australia

Status: RECRUITING

Clinical Research Site

Surry Hills, 2010 - Australia

Status: RECRUITING

Clinical Research Site

Sydney, 2010 - Australia

Status: RECRUITING

Clinical Research Site

Wollongong, 2500 - Australia

Status: RECRUITING

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Recurrent Genital Herpes Simplex Type 2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships